Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ 0.34 | $ 54.18M | 0.2 | 799.44M |
3/31/2025 | $ 0.38 | $ 60.08M | 0.2 | 784.28M |
12/31/2024 | $ 0.41 | $ 60.97M | 0.2 | 739.62M |
9/30/2024 | $ 0.47 | $ 72.54M | 0.2 | 770.15M |
6/30/2024 | $ 0.55 | $ 78.65M | 0.2 | 711.77M |
3/31/2024 | $ 0.31 | $ 42.84M | 0.2 | 700.26M |
12/31/2023 | $ 0.38 | $ 50.54M | 0.2 | 659.45M |
6/30/2023 | $ 0.56 | $ 72.18M | 0.2 | 643.2M |
12/31/2022 | $ 0.62 | $ 77.33M | 0.2 | 624.93M |
6/30/2022 | $ 0.74 | $ 86.98M | 0.2 | 584.91M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for MEREO BIOPHARMA GROUP PLC is calculated as follows: Equity [ $ -18.71M ] / (Shares WA [ 338.95M ] * Share Factor [ 0.2 ])
(=) BVPS [ $ -0.28 ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.99K |
---|---|
min | $ -30.1 |
max | $ 46.62 |
average | $ 10.27 |
median | $ 6.03 |
std | $ 12.43 |